Medical Communications
FDA weighs up divisive change to Alzheimer’s drug assessment
February 16, 2018 Medical Communications Alzheimer's, FDA, biotech, drugs, pharma, pharmaceutical
Roche boosts cancer efforts with $1.9 billion buyout of Flatiron Health
February 16, 2018 Medical Communications, Sales and Marketing Cancer, Flatiron health, Roche, acquisition, oncology, pharma
Silicon Valley-backed Celgene spin-off launches with $250m
February 16, 2018 Medical Communications, Sales and Marketing Celgene, Celularity, biotech, drugs, pharma, pharmaceutical
Taking a look behind the scenes of Serialisation
February 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation
MannKind entices Lilly VP to CMO role
February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical
SFO bribery investigation into GSK opens old wounds
February 9, 2018 Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
Top Ten most popular articles on Pharmafile.com this week
February 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma
Fujifilm partners with Takeda, stepping into regenerative medicine
February 9, 2018 Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical
FDA expands J&J Zytiga combo’s indication to include castration-sensitive prostate cancer
February 9, 2018 Medical Communications, Sales and Marketing Cancer, FDA, J&J, JJ, Janssen, Johnson & Johnson, Zytiga, pharma
Migraine drug bad news hits a weakened Teva
February 9, 2018 Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical
Stada poaches Novartis exec for fifth CEO in two years
February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment
Celgene Executive Chairman Bob Hugin retires
February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
New Year, new goals
February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma
Astellas confirms Kenji Yasukawa as new President and CEO
February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment
CEO gets the axe: Arcturus relieve Payne of position
February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical
Latest content
The evidence bar impacting UK medical cannabis access
Addressing the rheumatic disease diagnostic gap in primary care
